Whitehawk Therapeutics Inc. (WHWK)
WHWK trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.02
-10.65% on the day
Market cap
$172.2M
Micro cap
Revenue · 2025
$7.1M
-72.5% on 2024
Net income · 2025
-$20.6M
-288.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | WHWK on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001422142 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $7.1M |
| Net income | -$20.6M |
| Operating income | -$114.4M |
| Net margin | -288.3% |
| Operating margin | -1601.1% |
| Revenue growth | -72.5% |
| Cash | $37.6M |
| Total assets | $150.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 24.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-05-29 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-10 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 671 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| YARW | Yarrow Bioscience Inc. | $18.60 | -6.16% | $173.1M |
| PEPG | PepGen Inc. | $2.50 | +0.40% | $173.1M |
| NGEN | NervGen Pharma Corp. | $1.63 | -5.78% | $173.5M |
| ORMP | Oramed Pharmaceuticals Inc. | $4.17 | -2.34% | $173.5M |
| VRXA | Veraxa Biotech AG | $1.20 | +5.26% | $169.7M |
| ADAG | Adagene Inc. | $2.46 | -10.22% | $162.5M |
| LYEL | Lyell Immunopharma Inc. | $7.51 | -9.19% | $184.0M |
| CNTN | Canton Strategic Holdings Inc. | $2.02 | -4.26% | $161.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier